Study Links GLP-1 Weight-Loss and Diabetes Drugs to Slightly Higher Risk of Rare Vision Loss
Researchers have linked GLP-1 weight-loss and diabetes drugs to a slightly increased risk of a rare condition that can cause sudden, potentially permanent vision loss, Science Daily reported. The findings, summarized by science outlets this week, have renewed discussion of the eye safety of the widely used drug class.
GLP-1 drugs include several prescription medicines widely used in the United States for type 2 diabetes and weight management. The reported association comes from observational research and the absolute risk remains low; neither the study coverage nor clinicians advise patients to stop medication on their own — changes should be discussed with a doctor.
(Source: Science Daily)
Source: Science Daily
Published by GSM · USA (original Chinese edition)
Photo: 维基共享资源 · CC BY-SA 3.0 · 作者：Black Stripe
